What advances in CAR T for multiple myeloma have occurred since last year's meeting?

During the 2nd European CAR T Cell Meeting in Sitges, ES, the Multiple Myeloma Hub was delighted to speak to Hermann Einsele from University Hospital of Würzburg, Würzburg, DE. We asked: What advances in CAR T for multiple myeloma have occurred since last year's meeting?

Hermann Einsele discusses the new developments made in CAR T cell programs for patients with multiple myeloma. He explains that even though the patient populations are mainly made up of heavily pre-treated patients at a late stage of the disease there are studies that show a high response rate to CAR T therapy.